Clinical Trials Directory

Trials / Completed

CompletedNCT03679897

Comparison of 0.375% Ropivacaine and 0.25% Levobupivacaine for Infraclavicular Brachial Plexus Block

0.25% Levobupivacaine Versus 0.375% Ropivacaine: a Comparative Study in Ultrasound-Guided Infraclavicular Brachial Plexus Block

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
19 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Infraclavicular brachial plexus block has been used more frequently with the development of high-resolution ultrasound. Compared with peripheral nerve block using landmark technique or nerve stimulator technique, ultrasound-guided peripheral nerve block decreases the required dose of local anesthetics. As the dose of the drug used decreases, the systemic toxic effects of local anesthetics are reduced. However, the decreased dose of the drugs might have influence on the onset time of local anesthetics. Thus, the investigator aimed to evaluated the onset time of the two equipotent local anesthetics, 0.375% ropivacaine and 0.25% levobupivacaine.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine solutionultrasound-guided infraclavicular brachial plexus block with 0.375% ropivacaine solution
DRUGLevobupivacaine solutionultrasound-guided infraclavicular brachial plexus block with 0.25% levobupivacaine solution

Timeline

Start date
2018-09-18
Primary completion
2018-12-07
Completion
2018-12-08
First posted
2018-09-21
Last updated
2018-12-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03679897. Inclusion in this directory is not an endorsement.